Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ovid Therapeutics Inc. - Common Stock
(NQ:
OVID
)
1.840
+0.200 (+12.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ovid Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Curious about the stocks that are showing activity after the closing bell on Friday?
October 03, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why
October 03, 2025
The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures.
Via
Stocktwits
Topics
Intellectual Property
These stocks that are showing activity before the opening bell on Friday.
October 03, 2025
Wondering what's happening in Friday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 03, 2025
Via
Benzinga
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
October 03, 2025
Initial closing of approximately $81 million expected to fund current operating plan and clinical pipeline into 2028, with potential for up to $94 million in additional proceeds upon exercise of issued...
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
October 03, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Tuesday?
September 02, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 13, 2025
Via
Benzinga
Top movers in Wednesday's session
August 13, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
August 13, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
July 23, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Which stocks are moving after the closing bell on Tuesday?
July 22, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
July 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 27, 2025
Via
Benzinga
Get insights into the top gainers and losers of Friday's after-hours session.
June 27, 2025
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
Non-dilutive funding extends Ovid’s operational runway; Immedica assumes certain ganaxolone IP costs
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
June 05, 2025
Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results
May 13, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 24, 2025
Via
Benzinga
Top movers in Wednesday's after hours session
April 23, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 23, 2025
Via
Benzinga
Top movers in Wednesday's pre-market session
April 09, 2025
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 09, 2025
Via
Benzinga
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
April 02, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
March 03, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
February 27, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 05, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.